{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:17:41Z","timestamp":1794489461298,"version":"4.9.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"13","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Disease-defining signatures in lymphomas, driven by intricate molecular mechanisms, have advanced molecular taxonomies, refined classification, and may guide clinical management; however, the role of these signatures in driving disease hallmarks, including subtype-specific organotropism, remains largely unexplored. Primary mediastinal large B-cell lymphoma (PMBCL) is an exemplary lymphoma characterized by disease manifestations in the thymic niche, unique genetic alterations, and immune escape. Here, we identified interferon regulatory factor 4 (IRF4)\u2013C99R mutations uniquely occurring in PMBCL through mutational meta-analysis of large-scale data sets. By integrating multiomics approaches with genome editing in PMBCL cells, we revealed that IRF4-C99R contributes to a differentiation block phenotype. Specifically, we showed that IRF4-C99R reduces its binding to the interferon-stimulated response element (ISRE) motif within PRDM1, encoding a key transcriptional regulator of B-cell differentiation, resulting in decreased PRDM1 expression. Additionally, IRF4-C99R suppresses Traf2 and Nck-interacting kinase, a key interferon gamma (IFN-\u03b3) pathway regulator, by impairing ISRE motif binding, thereby reducing IFN-\u03b3 signaling and increasing thymus and activation-regulated chemokine (TARC) expression, which drives TARC-mediated chemotaxis of T regulatory cells. We also revealed that IRF4-C99R upregulates ephrin type-B receptor 1 (EPHB1) through noncanonical activating protein 1\u2013IRF composite motif binding and showed that overexpression of EPHB1 in an immunocompetent syngeneic lymphoma model influenced organotropism to favor thymic localization, without affecting overall tumor burden. IRF4-C99R mutation\u2013induced phenotypes were validated in primary PMBCL tissues using single-nuclei RNA sequencing, confirming that the molecular mechanisms observed in vitro align with the pathophysiology of PMBCL in patients. Together, these findings demonstrate how a single genetic mutation orchestrates the coordinated regulation of hallmark traits including thymus-specific tropism in PMBCL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2025028412","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T17:29:38Z","timestamp":1750440578000},"page":"1586-1600","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Somatic <i>IRF4<\/i> mutations and thymic tropism in primary mediastinal large B-cell lymphoma"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-9751","authenticated-orcid":false,"given":"Shinya","family":"Rai","sequence":"first","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"2Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-694X","authenticated-orcid":false,"given":"Gerben","family":"Duns","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Frontzek","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-6517","authenticated-orcid":false,"given":"Jasper C. H.","family":"Wong","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Yu","family":"Li","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kishida","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1122-6549","authenticated-orcid":false,"given":"Manabu","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"3Institute of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Healy","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vigan\u00f2","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-7595","authenticated-orcid":false,"given":"Aixiang","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"4Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Woolcock","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Telenius","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2867-4037","authenticated-orcid":false,"given":"Susana","family":"Ben-Neriah","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Meissner","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-0103","authenticated-orcid":false,"given":"Merrill","family":"Boyle","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisae","family":"Nakamura","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3541-684X","authenticated-orcid":false,"given":"Luke","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cassidy","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lytle","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-9391","authenticated-orcid":false,"given":"Pedro","family":"Farinha","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"4Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Slack","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-6586","authenticated-orcid":false,"given":"Laura K.","family":"Hilton","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-7800","authenticated-orcid":false,"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"5Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-8370","authenticated-orcid":false,"given":"Leandro","family":"Venturutti","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"4Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-8361","authenticated-orcid":false,"given":"Tomohiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"6Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-4560","authenticated-orcid":false,"given":"Nicole","family":"Wretham","sequence":"additional","affiliation":[{"name":"7Department of Experimental Therapeutics, British Columbia Cancer Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-2390","authenticated-orcid":false,"given":"Jonathan W.","family":"Bush","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-5038","authenticated-orcid":false,"given":"Laura","family":"Evgin","sequence":"additional","affiliation":[{"name":"8Michael Smith Genome Sciences Department, British Columbia Cancer Research Institute, Vancouver, BC, Canada"},{"name":"9Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-9863","authenticated-orcid":false,"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"10Department of Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-5947","authenticated-orcid":false,"given":"David W.","family":"Scott","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"10Department of Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-9750","authenticated-orcid":false,"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada"},{"name":"4Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2025092511214106800_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood.2020008376","article-title":"Primary mediastinal large B-cell lymphoma","volume":"140","author":"Savage","year":"2022","journal-title":"Blood"},{"issue":"18","key":"2025092511214106800_bib2","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","article-title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","volume":"131","author":"Vigan\u00f2","year":"2018","journal-title":"Blood"},{"issue":"22","key":"2025092511214106800_bib3","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"10","key":"2025092511214106800_bib4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2025092511214106800_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.23.01053","article-title":"Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes","volume":"42","author":"Noerenberg","year":"2024","journal-title":"J Clin Oncol"},{"issue":"18","key":"2025092511214106800_bib6","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1101\/gad.10.18.2335","article-title":"Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1","volume":"10","author":"Brass","year":"1996","journal-title":"Genes Dev"},{"issue":"16","key":"2025092511214106800_bib7","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1074\/jbc.274.16.11115","article-title":"SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1","volume":"274","author":"Rao","year":"1999","journal-title":"J Biol Chem"},{"issue":"7421","key":"2025092511214106800_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature11530","article-title":"BATF-JUN is critical for IRF4-mediated transcription in T cells","volume":"490","author":"Li","year":"2012","journal-title":"Nature"},{"issue":"7421","key":"2025092511214106800_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11531","article-title":"Compensatory dendritic cell development mediated by BATF-IRF interactions","volume":"490","author":"Tussiwand","year":"2012","journal-title":"Nature"},{"issue":"17","key":"2025092511214106800_bib10","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/cancers14174314","article-title":"IRF4 as an oncogenic master transcription factor","volume":"14","author":"Wong","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2025092511214106800_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10238-022-00968-0","article-title":"The dynamic functions of IRF4 in B cell malignancies","volume":"23","author":"Maffei","year":"2023","journal-title":"Clin Exp Med"},{"issue":"10","key":"2025092511214106800_bib12","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2011-04-350579","article-title":"IRF4 mutations in chronic lymphocytic leukemia","volume":"118","author":"Havelange","year":"2011","journal-title":"Blood"},{"issue":"18","key":"2025092511214106800_bib13","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1074\/jbc.RA117.000164","article-title":"An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia","volume":"293","author":"Cherian","year":"2018","journal-title":"J Biol Chem"},{"issue":"79","key":"2025092511214106800_bib14","doi-asserted-by":"crossref","first-page":"eade7953","DOI":"10.1126\/sciimmunol.ade7953","article-title":"A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency","volume":"8","author":"Fornes","year":"2023","journal-title":"Sci Immunol"},{"issue":"1","key":"2025092511214106800_bib15","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1038\/s41467-023-41954-8","article-title":"Transcriptional reprogramming by mutated IRF4 in lymphoma","volume":"14","author":"Schleussner","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"2025092511214106800_bib16","doi-asserted-by":"crossref","first-page":"e20221292","DOI":"10.1084\/jem.20221292","article-title":"A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency","volume":"220","author":"Thouenon","year":"2023","journal-title":"J Exp Med"},{"issue":"5","key":"2025092511214106800_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2025092511214106800_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"2025092511214106800_bib19","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1200\/JCO.23.00570","article-title":"Relapse timing is associated with distinct evolutionary dynamics in diffuse large B-cell lymphoma","volume":"41","author":"Hilton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"2025092511214106800_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"18","key":"2025092511214106800_bib21","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH [published correction appears in Blood. 2020;135(17):1507]","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2025092511214106800_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2025092511214106800_bib23","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","article-title":"Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma","volume":"9","author":"Arthur","year":"2018","journal-title":"Nat Commun"},{"issue":"7996","key":"2025092511214106800_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-023-06903-x","article-title":"Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling","volume":"625","author":"Alig","year":"2024","journal-title":"Nature"},{"issue":"7","key":"2025092511214106800_bib25","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","article-title":"Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas","volume":"35","author":"H\u00fcbschmann","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"2025092511214106800_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"7785","key":"2025092511214106800_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"1","key":"2025092511214106800_bib28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41467-022-28656-3","article-title":"Mutation-specific reporter for optimization and enrichment of prime editing","volume":"13","author":"Schene","year":"2022","journal-title":"Nat Commun"},{"issue":"7201","key":"2025092511214106800_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"2025092511214106800_bib30","doi-asserted-by":"crossref","first-page":"1213428","DOI":"10.3389\/fcvm.2023.1213428","article-title":"TNIK regulation of interferon signaling and endothelial cell response to virus infection","volume":"10","author":"Chau","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"4-5","key":"2025092511214106800_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1043-4666(03)00221-7","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma","volume":"23","author":"Xiao","year":"2003","journal-title":"Cytokine"},{"issue":"2","key":"2025092511214106800_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases","volume":"43","author":"Saeki","year":"2006","journal-title":"J Dermatol Sci"},{"issue":"1","key":"2025092511214106800_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.2002.1965","article-title":"IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)\/CCL17 and IP-10 (interferon-induced protein of 10kDA)\/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line","volume":"20","author":"Kakinuma","year":"2002","journal-title":"Cytokine"},{"key":"2025092511214106800_bib34","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1038\/ncomms12586","article-title":"TNIK inhibition abrogates colorectal cancer stemness","volume":"7","author":"Masuda","year":"2016","journal-title":"Nat Commun"},{"issue":"7","key":"2025092511214106800_bib35","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms25073834","article-title":"The clinical relevance of the EPH\/ephrin signaling pathway in pediatric solid and hematologic malignancies","volume":"25","author":"Chatzikalil","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025092511214106800_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cac2.12637","article-title":"Reciprocal tumor-platelet interaction through the EPHB1-EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma","volume":"45","author":"Yao","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"2025092511214106800_bib37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fimmu.2019.01473","article-title":"Emerging roles for Eph receptors and ephrin ligands in immunity","volume":"10","author":"Darling","year":"2019","journal-title":"Front Immunol"},{"key":"2025092511214106800_bib38","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1038\/ncomms14581","article-title":"Genomic characterisation of E\u03bc-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene","volume":"8","author":"Lefebure","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"2025092511214106800_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.2020007683","article-title":"Characterization of DLBCL with a PMBL gene expression signature","volume":"138","author":"Duns","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2025092511214106800_bib40","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.1201363","article-title":"Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment","volume":"190","author":"Rawal","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"2025092511214106800_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4110\/in.2015.15.3.161","article-title":"Early growth response-1 plays a non-redundant role in the differentiation of B cells into plasma cells","volume":"15","author":"Oh","year":"2015","journal-title":"Immune Netw"},{"issue":"35","key":"2025092511214106800_bib42","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1073\/pnas.0809784106","article-title":"Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB","volume":"106","author":"Porta","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2025092511214106800_bib43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"2025092511214106800_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2025092511214106800_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2025092511214106800_bib46","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.1201931","article-title":"Ephrin-B-dependent thymic epithelial cell-thymocyte interactions are necessary for correct T cell differentiation and thymus histology organization: relevance for thymic cortex development","volume":"190","author":"Cejalvo","year":"2013","journal-title":"J Immunol"},{"issue":"5","key":"2025092511214106800_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00418-014-1296-9","article-title":"Conditioned deletion of ephrinB1 and\/or ephrinB2 in either thymocytes or thymic epithelial cells alters the organization of thymic medulla and favors the appearance of thymic epithelial cysts","volume":"143","author":"Cejalvo","year":"2015","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"2025092511214106800_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/icb.2012.59","article-title":"Eph\/ephrinB signalling is involved in the survival of thymic epithelial cells","volume":"91","author":"Garc\u00eda-Ceca","year":"2013","journal-title":"Immunol Cell Biol"},{"issue":"11","key":"2025092511214106800_bib49","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"issue":"3","key":"2025092511214106800_bib50","first-page":"251","article-title":"Primary large cell lymphoma of the mediastinum","volume":"26","author":"Aisenberg","year":"1999","journal-title":"Semin Oncol"},{"issue":"10","key":"2025092511214106800_bib51","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","article-title":"Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma","volume":"105","author":"Renn\u00e9","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2025092511214106800_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/PAS.0000000000001154","article-title":"Cyclin D1-positive mediastinal large B-cell lymphoma with copy number gains of CCND1 gene: a study of 3 cases with nonmediastinal disease","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2025092511214106800_bib53","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00428-023-03550-5","article-title":"Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology","volume":"483","author":"Gibson","year":"2023","journal-title":"Virchows Arch"},{"key":"2025092511214106800_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-031-77921-3_11","article-title":"Age-related thymic involution","volume":"1471","author":"Lins","year":"2025","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"2025092511214106800_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0000000000000119","article-title":"Primary mediastinal classical Hodgkin lymphoma","volume":"23","author":"Pi\u00f1a-Oviedo","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"2025092511214106800_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/13\/1586\/2413158\/blood_bld-2025-028412-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/13\/1586\/2413158\/blood_bld-2025-028412-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:21:53Z","timestamp":1758813713000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/13\/1586\/537880\/Somatic-IRF4-mutations-and-thymic-tropism-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":56,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028412","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,25]]},"published":{"date-parts":[[2025,9,25]]}}}